Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | BMY | AMGN | GILD | VRTX |
| Company | Aslan Pharmaceuticals Ltd ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7301 | 72.59 | 253.46 | 83.52 | 321.21 |
| High | 0.7400 | 72.91 | 254.16 | 83.84 | 322.69 |
| Low | 0.6800 | 71.88 | 250.60 | 82.33 | 319.23 |
| Last | 0.6800 | 72.03 | 251.59 | 83.35 | 319.98 |
| Change | -0.0649 | -0.42 | -2.06 | -0.38 | -1.47 |
| % Change | -8.71% | -0.58% | -0.81% | -0.45% | -0.46% |
| Volume | 210,400 | 8,900,500 | 2,042,700 | 7,283,000 | 2,261,700 |
| 20-Day Average Volume | 230,300 | 8,124,960 | 2,081,785 | 6,016,035 | 1,444,045 |
| Previous Close | 0.7449 | 72.45 | 253.65 | 83.73 | 321.45 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6445 | 72.45 | 264.34 | 84.99 | 302.19 |
| 20-Day Raw Stochastic | 73.33% | 30.12% | 3.77% | 20.06% | 91.10% |
| 20-Day Relative Strength | 57.50% | 43.32% | 34.06% | 46.74% | 61.66% |
| Weighted Alpha | -65.45 | +5.40 | +8.80 | +36.20 | +31.60 |
| Today's Opinion | 40% Buy | 56% Sell | 8% Sell | 40% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 56% Sell | 8% Buy | 40% Buy | 72% Buy |
| Last Month's Opinion | 88% Sell | 8% Sell | 40% Buy | 80% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.34% since 01/23/23 | -1.68% since 01/23/23 | -3.59% since 01/23/23 | +0.14% since 01/23/23 | +2.62% since 01/23/23 |
| Low | 0.6800 on 01/30/23 | 71.88 on 01/30/23 | 250.60 on 01/30/23 | 82.11 on 01/24/23 | 309.53 on 01/24/23 |
| High | 0.8000 on 01/24/23 | 75.00 on 01/24/23 | 262.00 on 01/24/23 | 84.55 on 01/25/23 | 323.67 on 01/27/23 |
| 1-Month | |||||
| %Chg | +88.89% since 12/30/22 | +0.11% since 12/30/22 | -4.21% since 12/30/22 | -2.91% since 12/30/22 | +10.80% since 12/30/22 |
| Low | 0.3700 on 01/03/23 | 70.75 on 01/09/23 | 250.60 on 01/30/23 | 82.11 on 01/24/23 | 282.21 on 01/09/23 |
| High | 0.8000 on 01/24/23 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 323.67 on 01/27/23 |
| 3-Month | |||||
| %Chg | +69.96% since 10/28/22 | -6.25% since 10/28/22 | -8.12% since 10/28/22 | +5.15% since 10/28/22 | +1.94% since 10/28/22 |
| Low | 0.3405 on 11/02/22 | 70.75 on 01/09/23 | 250.60 on 01/30/23 | 77.16 on 11/03/22 | 282.21 on 01/09/23 |
| High | 0.8000 on 01/24/23 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 324.75 on 12/08/22 |
| 6-Month | |||||
| %Chg | +46.84% since 07/29/22 | -2.37% since 07/29/22 | +1.66% since 07/29/22 | +39.50% since 07/29/22 | +14.11% since 07/29/22 |
| Low | 0.3405 on 11/02/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 59.27 on 08/01/22 | 271.61 on 08/03/22 |
| High | 0.9890 on 08/15/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 324.75 on 12/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 51,953 | 154,040,288 | 135,342,304 | 105,017,856 | 82,513,328 |
| Shares Outstanding, K | 69,745 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -31,320,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 0 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -10,929,706 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | 1.64 | 0.44 | 0.67 | 0.45 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 10/28/22 | 1.99 on 10/25/22 | 4.70 on 11/03/22 | 1.90 on 10/27/22 | 4.01 on 10/27/22 |
| Latest Earnings Date | 03/24/23 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.47 | 14.19 | 13.29 | 24.30 |
